Summary
Updated Aug 30, 2026
Nicholas A. Saccomano is President and CEO, Director of OnKure Therapeutics, Inc. (OKUR). 6 SEC Form 4 filings on record going back to 2024, most recently on 11 August 2026. Most recent open-market trade: sold $378 of OKUR on 24 June 2026. Lifetime open-market sales: $966.
Recent Transactions
4Every recent SEC Form 4 transaction Nicholas A. Saccomano has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nicholas A. Saccomano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason A. Leverone - $3K of OKUR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nicholas A. Saccomano?
Nicholas A. Saccomano is a corporate insider, tracked as President and CEO, Director of OnKure Therapeutics, Inc. (OKUR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nicholas A. Saccomano submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Nicholas A. Saccomano been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($966) across all tracked filings.
Where can I see all of Nicholas A. Saccomano's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nicholas A. Saccomano and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
